483
Organon Pharma (UK) Ltd.Organon Pharma (UK) Ltd. – FDA 483, Jun 13, 2025
Record Details
An FDA inspection of Organon Pharma (UK) Ltd. in Cramlington, United Kingdom, a drug manufacturer, revealed three significant observations. Deficiencies included inadequate testing of components used in drug product manufacturing, failure to follow quality control unit procedures for labeling rejected materials, and insufficient cleaning validation studies for non-dedicated equipment, potentially leading to contamination.
View Company Profile
ID · 276787d1-49b1-4312-b31b-db090512c3cb
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.